These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4609906)

  • 1. Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli.
    Donaldson DM; Roberts RR; Larsen HS; Tew JG
    Infect Immun; 1974 Sep; 10(3):657-66. PubMed ID: 4609906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased antibacterial activity against Escherichia coli in bovine serum after the induction of endotoxin tolerance.
    Hill AW; Shears AL; Hibbitt KG
    Infect Immun; 1976 Jul; 14(1):257-65. PubMed ID: 780275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of human serum beta-lysin by sodium polyanetholsulfonate and sodium amylosulfate.
    Traub WH; Fukushima PI
    J Clin Microbiol; 1979 Jul; 10(1):19-26. PubMed ID: 227918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors involved in bactericidal activity of sheep serum.
    Mittal KR; Ingram DG
    Am J Vet Res; 1975 Aug; 36(08):1183-7. PubMed ID: 1098531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.
    Martinez RJ; Carroll SF
    Infect Immun; 1980 Jun; 28(3):735-45. PubMed ID: 6156906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of staphylocidal beta-lysin from rabbit serum.
    Johnson FB; Donaldson DM
    J Bacteriol; 1968 Sep; 96(3):589-95. PubMed ID: 4979097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killing of an encapsulated strain of Escherichia coli by human serum.
    Taylor PW; Kroll HP
    Infect Immun; 1983 Jan; 39(1):122-31. PubMed ID: 6185430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement-dependent bacteriolytic activity of normal human serum. I. The effect of pH and ionic strength and the role of lysozyme.
    WARDLAW AC
    J Exp Med; 1962 Jun; 115(6):1231-49. PubMed ID: 14004953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
    J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of the alternative complement pathway generated from 11 isolated plasma proteins.
    Schreiber RD; Morrison DC; Podack ER; Müller-Eberhard HJ
    J Exp Med; 1979 Apr; 149(4):870-82. PubMed ID: 372483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli.
    Pellegrini A; Thomas U; Wild P; Schraner E; von Fellenberg R
    Microbiol Res; 2000 Jul; 155(2):69-77. PubMed ID: 10950188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems.
    Wilson LA; Spitznagel JK
    J Bacteriol; 1968 Oct; 96(4):1339-48. PubMed ID: 4879562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction.
    Feingold DS; Goldman JN; Kuritz HM
    J Bacteriol; 1968 Dec; 96(6):2118-26. PubMed ID: 4972918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal effect of complement and lysozyme on polymyxin-treated, serum-resistant gram-negative bacilli.
    Fierer J; Finley F
    J Infect Dis; 1979 Oct; 140(4):581-9. PubMed ID: 229175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killing of Gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement proteins in the death of Salmonella strains O48.
    Bugla-Płoskońska G; Kiersnowski A; Futoma-Kołoch B; Doroszkiewicz W
    Microb Ecol; 2009 Aug; 58(2):276-89. PubMed ID: 19294463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes.
    Heddle RJ; Knop J; Steele EJ; Rowley D
    Immunology; 1975 Jun; 28(6):1061-6. PubMed ID: 1093969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. 3. Isolation of a gammag normal antibody and characterization of other serum factors causing P32 loss.
    Spitznagel JK
    J Bacteriol; 1966 Jan; 91(1):401-8. PubMed ID: 4159313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of purified lipopolysaccharide on the bactericidal reaction of human serum complement.
    Allen RJ; Scott GK
    J Gen Microbiol; 1980 Mar; 117(1):65-72. PubMed ID: 6993628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.